madam of course it's "potential" - it is a TRIAL
can you not voice any positive aspect of this trial? You are such a negative fellow.
madam asked this ......"What do you think the reason(s) is(are) for that stark long-term divergence in potential and share price?"
This has been discussed enough and any answer I provide will probably be treated with derision and sarcasm. If you had some interest or some knowledge of the science and technology you would better understand the complexities involved in pioneering this sort of cellular biochemistry/immunology etc especially where it has to prove itself to be better than current medicines. Developing a disruptive technology such as this up against the industry incumbents and all the frankly ignorant and instinctively negative bystanders is about as tough as an assignment as can be imagined. Since there is no "rear vision mirror" many difficulties on the journey cannot be forecast. Clearly also the market underestimated what was involved to get the technology to where it currently is. But this should not change ones opinion of the chances that Mesoblast will be successful.
Hence the prior premature elevated share price. However this does not detract from or lessen the opportunities that Mesoblast is presented with. Indeed they have never been more exciting.
Madam I think your negativity is unwarranted and I hope that one day you will look at Mesoblast through a different prism. Would take a lot of courage to change your opinion at this late stage but I don't think that is beyond you. This remark also applies to your colleague and friend hottuna.
- Forums
- ASX - By Stock
- things I've learnt over the last 14 months
madam of course it's "potential" - it is a TRIAL can you not...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 37637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | 1.015 |
8 | 195410 | 1.010 |
5 | 95607 | 1.005 |
7 | 208096 | 1.000 |
3 | 103747 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 37637 | 1 |
1.030 | 29757 | 2 |
1.035 | 91225 | 3 |
1.040 | 72457 | 5 |
1.045 | 126212 | 4 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online